Skip to main content

Oluwadamilola Motunrayo Fayanju, MD, MA, MPHS

Associate Professor of Surgery
Associate Professor in Population Health Sciences
Campus Mail: DUMC DUMC 3513, Durham, NC 27710

Dr. Fayanju is an Associate Professor of Surgery and Population Health Sciences in the Duke University School of Medicine, Associate Director for Disparities & Value in Healthcare with Duke Forge (the university’s center for actionable data science: https://forge.duke.edu/oluwadamilola-fayanju-md-ma-mphs), and Director of the Durham VA Breast Clinic.

She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.

Her research, which is supported by an NIH K08 career development award, has 3 areas of focus: (1) addressing disparities in breast cancer presentation, treatment, outcome, and clinical trial participation; (2) improving prognostication and treatment for biologically aggressive variants of breast cancer that are often more common among racial and ethnic minorities; and (3) creating value in oncologic care, especially through the collection and application of patient-reported outcomes (PROs). Her scholarship has been published in a variety of journals including Annals of Surgery, Cancer, and JAMA.

She is active in several national organizations, currently serving on the Board of Directors for the Surgical Outcomes Club and on various committees including the Breast, Cancer Care Delivery, and Health Disparities Committees for the Alliance for Clinical Trials in Oncology; the Patient-reported Outcomes, Patient Safety and Quality, and Publications Committees for the American Society of Breast Surgeons (ASBrS); the Nominating and Program Committees for the Association for Academic Surgery (AAS); the Women in Surgery Committee for the Society of Black Academic Surgeons (SBAS); and the Locoregional and Patient-reported Outcomes Committees for the Translational Breast Cancer Research Consortium (TBCRC).

Education and Training

  • Breast Surgical Oncology Fellow, Surgery, University of Texas MD Anderson Cancer Center, 2015 - 2016
  • General Surgery Resident, Surgery, Washington University School of Medicine, 2007 - 2015
  • M.P.H.S., Washington University School of Medicine, 2011
  • M.D., Washington University School of Medicine, 2007
  • M.A., Harvard University , 2001
  • A.B., Harvard University , 2001

Publications

Gehlert, Sarah, Oluwadamilola M. Fayanju, Sherrill Jackson, Sandi Kenkel, Isaac C. McCullough, Cheryl Oliver, and Mark Sanford. “A method for achieving reciprocity of funding in community-based participatory research.” Prog Community Health Partnersh 8, no. 4 (2014): 561–70. https://doi.org/10.1353/cpr.2014.0054.

Full Text

Fayanju, Oluwadamilola M., Carolyn R. T. Stoll, Susan Fowler, Graham A. Colditz, Donna B. Jeffe, and Julie A. Margenthaler. “Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.” Ann Surg Oncol 20, no. 10 (October 2013): 3308–16. https://doi.org/10.1245/s10434-013-3157-5.

Full Text

Fayanju, Oluwadamilola, Carolyn Stoll, Graham Colditz, Donna Jeffe, and Julie Margenthaler. “Geographic and Temporal Trends in the Management of Occult Primary Breast Cancer: A Systematic Review and Meta-Analysis.” In Annals of Surgical Oncology, 20:41–42. SPRINGER, 2013.

Scholars@Duke

Fayanju, Oluwadamilola, Donna Jeffe, and Julie Margenthaler. “Management of Occult Primary Breast Cancer at a National Cancer Institute-Designated Comprehensive Cancer Center.” In Annals of Surgical Oncology, 20:40–40. SPRINGER, 2013.

Scholars@Duke

Fayanju, Oluwadamilola M., Donna B. Jeffe, Leisha Elmore, Deborah N. Ksiazek, and Julie A. Margenthaler. “Patient and process factors associated with late-stage breast cancer diagnosis in Safety-Net patients: a pilot prospective study.” Ann Surg Oncol 20, no. 3 (March 2013): 723–32. https://doi.org/10.1245/s10434-012-2558-1.

Full Text

Fayanju, O. M., C. Stoll, G. A. Colditz, and J. A. Margenthaler. “Contralateral Prophylactic Mastectomy after Unilateral Breast Cancer: A Systematic Review and Meta-Analysis.” In Annals of Surgical Oncology, 20:S65–66. SPRINGER, 2013.

Scholars@Duke

Fayanju, O. M., Y. Yan, D. B. Jeffe, and J. A. Margenthaler. “High Tumor Grade Predicts Pathologic Complete Response in Breast Cancer Patients after Neoadjuvant Chemotherapy.” In Annals of Surgical Oncology, 20:S46–S46. SPRINGER, 2013.

Scholars@Duke

Fayanju, Oluwadamilola M., Susan Kraenzle, Bettina F. Drake, Xuemei Si, Masayoshi Oka, and Melody S. Goodman. “Barriers to mammography among underserved women in a breast health center outreach program.” In Journal of Clinical Oncology, 30:13–13. American Society of Clinical Oncology (ASCO), 2012. https://doi.org/10.1200/jco.2012.30.27_suppl.13.

Full Text

Fayanju, Oluwadamilola M., Donna B. Jeffe, Jennifer R. Tappenden, Courtney E. Beers, Bettina F. Drake, Feng Gao, and Julie A. Margenthaler. “Breast cancer presentation in an urban health care Safety Net system.” Mo Med 109, no. 5 (September 2012): 405–11.

Scholars@Duke

Pages